Suppr超能文献

BRCA1 和 MSH6 胚系截短突变与早发性子宫内膜癌。

Germline truncating-mutations in BRCA1 and MSH6 in a patient with early onset endometrial cancer.

机构信息

Department of Gynecology and Obstetrics, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

出版信息

BMC Cancer. 2012 Nov 20;12:531. doi: 10.1186/1471-2407-12-531.

Abstract

BACKGROUND

Hereditary Breast and Ovarian Cancer Syndrome (HBOCS) and Hereditary Non-Polyposis Colorectal Cancer Syndrome (HNPCC, Lynch Syndrome) are two tumor predisposition syndromes responsible for the majority of hereditary breast and colorectal cancers. Carriers of both germline mutations in breast cancer genes BRCA1 or BRCA2 and in mismatch repair (MMR) genes MLH1, MSH2, MSH6 or PMS2 are very rare.

CASE PRESENTATION

We identified germline mutations in BRCA1 and in MSH6 in a patient with increased risk for HBOC diagnosed with endometrial cancer at the age of 46 years.

CONCLUSIONS

Although carriers of mutations in both MMR and BRCA genes are rare in Caucasian populations and anamnestical and histopathological findings may guide clinicians to identify these families, both syndromes can only be diagnosed through a complete gene analysis of the respective genes.

摘要

背景

遗传性乳腺癌和卵巢癌综合征(HBOCS)和遗传性非息肉病性结直肠癌综合征(HNPCC,林奇综合征)是两种肿瘤易感性综合征,负责大多数遗传性乳腺癌和结直肠癌。携带有乳腺癌基因 BRCA1 或 BRCA2 以及错配修复(MMR)基因 MLH1、MSH2、MSH6 或 PMS2 种系突变的患者非常罕见。

病例介绍

我们在一名 46 岁患有子宫内膜癌的 HBOC 高风险患者中发现了 BRCA1 和 MSH6 的种系突变。

结论

尽管在白种人群中 MMR 和 BRCA 基因突变的携带者非常罕见,并且临床病史和组织病理学发现可能有助于临床医生识别这些家族,但这两种综合征只能通过对相应基因的完整基因分析来诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4b3/3537684/a4a2b993a908/1471-2407-12-531-1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验